Welireg
Ended Awarded Last action
- Contract number
- 36C26024F0608
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $64,068
Award facts
- Contract value 100% obligated
- $64,067.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$198,463 | |
| Funding Only Action | $22,952 | |
| Original award | $239,578 |
About this award
Merck Sharp & Dohme LLC (Merck) received a delivery order award from Veterans Integrated Service Network 20 (VISN 20), an operational component of the Department of Veterans Affairs, for the 2025 price increase associated with Welireg (belzutifan), a pharmaceutical treatment for renal cell carcinoma. The contract, awarded on August 28, 2024, carries a ceiling value of $64,067.64 under firm fixed-price terms with an ultimate completion date of August 28, 2025. This delivery order is issued under a parent Indefinite Delivery Vehicle on the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which establishes Merck as an authorized supplier of pharmaceutical products to federal healthcare programs. No set-aside designation was applied to this award, indicating open and competitive procurement.
The award reflects the VA's continued reliance on Merck as a critical supplier for advanced oncology therapeutics within its healthcare network. VISN 20 serves a multi-state region and utilizes the GSA schedule contract to procure essential pharmaceutical products, including specialty drugs for cancer treatment, for eligible veterans. This delivery order specifically addresses the annual price adjustment for Welireg inventory, which supports the VA's commitment to providing comprehensive cancer care to the veteran population served by VISN 20 at the performance location in Carrollton, Texas.
Quick answers
Who was awarded contract 36C26024F0608?
36C26024F0608 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on August 28, 2024.
How much is contract 36C26024F0608 worth?
The government has obligated $64,068 on 36C26024F0608.
Is contract 36C26024F0608 an order under another contract?
Yes. 36C26024F0608 is a delivery order under 36F79718D0509, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0608 competed?
The extent of competition for 36C26024F0608 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award